Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of the anti-inflammatory effect between original and generic salmeterol/fluticasone propionate in asthma
TCTR20260327004Phase 3Not yet recruiting
- Sponsor
- AdaptHealth
- Start
- May 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of salmeterol + fluticasone in asthma, sponsored by AdaptHealth. Planned start May 2025; status: not yet recruiting.
02
Drugs
salmeterol + fluticasone
03
Conditions
asthma
Beyond the preview
Go deeper on TCTR20260327004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20260327004.